Residual inflammatory risk post STEMI: high prevalence despite LDL-C control and association with other secondary prevention targets - Scorecard - MDSpire

Residual inflammatory risk post STEMI: high prevalence despite LDL-C control and association with other secondary prevention targets

  • By

  • Ahmed Hassan

  • Amr Yosry Emam

  • Mina Samir

  • Kerolos Sobhy

  • Ihab Abd El Nabi

  • Hala Ali

  • Mohammed Thabet

  • Ahmed Elghazoly

  • Nagwa Thabet

  • Ahmed Elguindy

  • May 29, 2026

  • 0 min

Share

Clinical Scorecard: Post-STEMI Inflammatory Risk: Common Occurrence Despite LDL-C Management and Links to Secondary Prevention Goals

At a Glance

CategoryDetail
ConditionResidual inflammatory risk after ST-elevation myocardial infarction (STEMI)
Key MechanismsHigh-sensitivity C-reactive protein (hs-CRP) as a marker of inflammation
Target PopulationPatients post-primary percutaneous coronary intervention (pPCI) for STEMI
Care SettingCardiovascular follow-up care

Key Highlights

  • 44.6% of patients had elevated hs-CRP levels (>3 mg/L)
  • 29.8% of patients with LDL-C < 55 mg/dL still exhibited elevated hs-CRP
  • Achieving secondary prevention targets correlates with lower hs-CRP levels
  • Comprehensive secondary prevention includes lipid management and medication adherence

Guideline-Based Recommendations

Diagnosis

  • Use hs-CRP to assess residual inflammatory risk post-STEMI

Management

  • Focus on achieving LDL-C < 55 mg/dL, waist circumference reduction, and medication adherence

Monitoring & Follow-up

  • Regular assessment of hs-CRP levels and secondary prevention metrics

Risks

  • Persistent inflammatory risk despite optimal LDL-C management

Patient & Prescribing Data

878 patients who underwent pPCI for STEMI

Statin and ACEI/ARB therapy adherence associated with lower hs-CRP

Clinical Best Practices

  • Implement comprehensive secondary prevention strategies
  • Monitor hs-CRP levels alongside traditional risk factors
  • Encourage lifestyle modifications for cardiovascular risk reduction

Related Resources & Content

Original Source(s)

Residual inflammatory risk post STEMI: high prevalence despite LDL-C control and association with other secondary prevention targets

  • by Ahmed Hassan, Amr Yosry Emam, Mina Samir, Kerolos Sobhy, Ihab Abd El Nabi, Hala Ali, Mohammed Thabet, Ahmed Elghazoly, Nagwa Thabet, Ahmed Elguindy

  • May 29, 2026

Related Content

Drug-coated balloons vs. drug-eluting stents for coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials with lesion-specific insights

Side Effects: Variety Is Overrated

The organ you forgot, the cells that age unevenly, the AI that admits ignorance, and the diet advice that sounds wrong but isn't: medicine's next moves are hiding in plain sight.

Association between the C-reactive protein-triglyceride-glucose index and major adverse cardiovascular events in patients undergoing percutaneous coronary intervention